• Aenova, the world’s leading contract development and manufacturer for the pharmaceutical and healthcare industries, has achieved silver status in the latest EcoVadis sustainability rating.
  • This documents the Aenova Group’s continuous improvement of its sustainability in the categories “environment”, “labor and human rights”, “ethics” and “sustainable procurement”.

Starnberg, May 10, 2022 – Certified proof of sustainability in the areas of environment, labor, ethics and procurement is becoming increasingly important for companies and their suppliers. Almost half of the world’s leading pharmaceutical companies use the EcoVadis assessment for this purpose. The Aenova Group also submits to the annual EcoVadis assessment and scored this year with a significant improvement from bronze to silver medal. In the areas of environment and labor and human rights, the best results were achieved with 70 out of 100 maximum possible points. With a percentile of 84, Aenova is among the top 25 per cent of companies assessed by EcoVadis.

“The production steps in the pharmaceutical industry are energy-intensive. Our good result also distinguishes our responsible approach to natural resources,” explains Dr. Pedro Diaz-Kraus, Vice President of Corporate HSES and responsible for the EcoVadis project at Aenova. “We are very pleased that we have now been able to improve our sustainability score from bronze to silver!”

“Sustainability is not an empty phrase for us, but an important strategic goal,” says Jan Kengelbach, CEO of Aenova Group. “Our sustainability strategy always includes further optimization in sustainability and environmental topics. For example, the Aenova site in Sisseln already operates completely CO2 -free, many sites have photovoltaic systems as well as special wastewater treatment or their own combined heat and power plants, and we are continuously expanding the sites.”

The EcoVadis methodology covers a total of seven management indicators, comprising 21 sustainability criteria in four thematic areas: Environment, Labor and Human Rights, Ethics and Sustainable Procurement. It is based on leading standards such as GRI (Global Reporting Initiative), UNCC (UN Climate Change) and ISO 26000, and is overseen by an international scientific committee. It evaluates companies’ performance by analyzing policies, measures and results. For Aenova, the next ranking is due in early 2023.

The Aenova Group was awarded the EcoVadis Silver Medal in 2022, placing it among the top 25% of companies evaluated

About Aenova Group

The Aenova Group is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industry. As a one-stop store, Aenova develops, produces and­ packages all common dosage forms, product groups and active ingredient classes from pharmaceuticals to dietary supplements for human and animal health: solid, semi-solid and liquid, sterile and non-sterile, high and low dose, OEB 1 to 5 (Occupational Exposure Band). Approximately 4,200 employees at 16 sites in Europe and the U.S. contribute to the company’s success. For more information, visit

Press contact

Dr. Susanne Knabe
Head of Corporate Communication & PR

Aenova Holding GmbH

Berger Straße 8 – 10

D-82319 Starnberg


Mobile: +49 170 22 368 42